ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629301 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629301; 2) Community: the network communities that were significantly associated with the response to NSC 629301; 3) Molecule: the relationships between components within communities and NSC 629301; 4) MDR: the compounds that were significantly associated with the NSC 629301.

NSC Compound Enrichment Correlation
NSC 666124 Null 0.0329129886465387 0.24614537
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.0329129886465387 0.17078101
NSC 688228 Null 0.0329129886465387 0.27083309
NSC 700862 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- 0.0329129886465387 0.52506994
NSC 700906 [1-Methyl-4-[1-methyl-4-(3-methoxysulfonyl)propanamido]pyrole-2-carboxamido]propane 0.0329129886465387 0.28459322
NSC 716002 Null 0.0329129886465387 0.2271469
NSC 718781 Erlotinib hydrochloride 0.0329129886465387 -0.13873337
NSC 726217 Combretastatin A4-analogue 0.0329129886465387 0.18765732
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0329129886465387 0.20599799
NSC 741425 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide 0.0329129886465387 0.45101326
Total:81  Current:59    [First] [Prev] [Next] [Last]